DRTG(SH:600329) Zheng Xing Xing Ye Ri Bao·2025-09-17 08:42Market Overview - On September 17, the Chinese medicine sector fell by 0.19%, with Darentang leading the decline [1] - The Shanghai Composite Index closed at 3876.34, up 0.37%, while the Shenzhen Component Index closed at 13215.46, up 1.16% [1] Stock Performance - Notable gainers in the Chinese medicine sector included: - ST Xiangxue: Closed at 11.49, up 8.29% with a trading volume of 289,200 shares and a turnover of 320 million yuan [1] - Enwei Pharmaceutical: Closed at 34.98, up 3.49% with a trading volume of 18,300 shares and a turnover of 63.37 million yuan [1] - Major decliners included: - Darentang: Closed at 44.44, down 2.39% with a trading volume of 78,900 shares and a turnover of 35.2 million yuan [2] - ST Changyao: Closed at 3.92, down 2.00% with a trading volume of 102,100 shares and a turnover of 39.94 million yuan [2] Capital Flow - The Chinese medicine sector experienced a net outflow of 593 million yuan from institutional investors, while retail investors saw a net inflow of 527 million yuan [2][3] - The table of capital flow indicates that: - Jilin Aodong had a net inflow of 18.77 million yuan from institutional investors, but a net outflow from retail investors [3] - ST Xiangxue also saw a net inflow from institutional investors but a significant outflow from retail investors [3]